TG
AGIO icon

TCW Group’s Agios Pharmaceuticals AGIO Stock Holding History

TCW Group’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-15,661
Closed -$1.75M – 746
2014
Q4 		$1.75M Sell
15,661
-18,288
-54% -$1.63M 0.01% 636
2014
Q3 		$2.08M Sell
33,949
-1,717
-5% -$74K 0.01% 663
2014
Q2 		$1.63M Sell
35,666
-2,993
-8% -$122K 0.01% 683
2014
Q1 		$1.51M Sell
38,659
-14,985
-28% -$501K 0.01% 694
2013
Q4 		$1.28M Sell
53,644
-17,312
-24% -$395K 0.01% 702
2013
Q3 		$1.98M Buy
+70,956
New +$1.96M 0.01% 662

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CGT
Capital Guardian Trust Los Angeles, California $7.42B AUM 13.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

TCW Group's AGIO Position: Q1 2015 in Review

TCW Group sold out of Agios Pharmaceuticals (AGIO) in Q1 2015, closing a stake of 15,661 shares — an estimated $1.75M sold.

TCW Group first reported a position in AGIO in Q3 2013 and held it in 6 quarters. The position peaked at $2.08M in Q3 2014. 152 funds tracked by Wall St. Rank hold AGIO as of Q1 2015.

  • TCW Group reported no remaining Agios Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • TCW Group sold 15,661 Agios Pharmaceuticals shares in Q1 2015, an estimated $1.75M.
  • TCW Group first reported a position in Agios Pharmaceuticals in Q3 2013 and held it in 6 quarters.
  • TCW Group's Agios Pharmaceuticals position peaked at $2.08M in Q3 2014.
  • 152 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2015.

Based on TCW Group's 13F filing for Q1 2015, filed 13 May 2015.